Trial Profile
Pilot Study with Treatment of Short Bowel Syndrome Patients with end-jejunostomi with the Glucagon-Like Peptide-1 analogue, Liraglutide (Victoza) Pilotstudie med behandling af korttarmspatienter med glucagon-like peptide-1 analogen, liraglutide (Victoza)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 11 Nov 2014
Price :
$35
*
At a glance
- Drugs Liraglutide (Primary)
- Indications Short bowel syndrome
- Focus Therapeutic Use
- 02 Jul 2014 According to the European Clinical Trials database record, status changed from recruiting to completed.
- 02 Jul 2014 New trial record